Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes. The SANDS (Stop Atherosclerosis in Native Diabetics Study) Trial

Journal of the American College of Cardiology

Volumn 52, Issue 25, 2008, Pages 2198-2205

  Fleg, Jerome L ^a   Mete, Mihriye ^b   Howard, Barbara V ^b   Umans, Jason G ^b   Roman, Mary J ^c   Ratner, Robert E ^b   Silverman, Angela ^b   Galloway, James M ^d   Henderson, Jeffrey A ^e   Weir, Matthew R ^f   Wilson, Charlton ^g   Stylianou, Mario ^a   Howard, Wm James ^h  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e Black Hills Center for American Indian Health   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g PHOENIX INDIAN MEDICAL CENTER   (United States)

^h WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

atherosclerosis; carotid artery intima media thickness; ezetimibe

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; EZETIMIBE; FIBRIC ACID DERIVATIVE; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; ORAL ANTIDIABETIC AGENT;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CHOLESTEROL, LDL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA; TUNICA MEDIA;

EID: 57449105069     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.10.031     Document Type: Article

References (17)

1. Jackevicius C.A., Tu J.V., Ross J.S., Ko D.T., and Krumholz H.M. Use of ezetimibe in the United States and Canada. N Engl J Med 358 (2008) 1819-1828
2. Bruckert E., Giral P., and Tellier P. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption. Circulation 107 (2003) 3124-3128
3. Kastelein J.J., Akdim F., Stroes E.S., et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 358 (2008) 1431-1443
4. Howard B.V., Roman M.J., Devereux R.B., et al. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA 299 (2008) 1678-1689
5. Howard B.V., Lee E.T., Cowan L.D., et al. Rising tide of cardiovascular disease in American Indians: the Strong Heart Study. Circulation 99 (1999) 2389-2395
6. Howard B.V., Robbins D.C., Sievers M.L., et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL. Arterioscler Thromb Vasc Biol 20 (2000) 830-835
7. Russell M., Fleg J.L., Galloway W.J., et al. Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes-the Stop Atherosclerosis in Native Diabetics Study (SANDS). Am Heart J 152 (2006) 867-875
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
9. Allain C.C., Poon L.S., Chan C.S., et al. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
10. Ortho-Clinical Diagnostics, a Johnson & Johnson Company. Cholesterol. Pub. No. MP2-35 (2000) 1-10
11. Devereux R.B., and Roman M.J. Evaluation of cardiac and vascular structure by echocardiography and other noninvasive techniques. In: Laragh J.H., and Brenner B.M. (Eds). Hypertension: Pathophysiology, Diagnosis, Management. 2nd edition (1995), Raven Press, New York 1969-1985
12. Roman M.J., Saba P.S., Pini R., et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 86 (1992) 1909-1918
13. Rossebø A.B., Pedersen T.R., Boman K., et al., SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 359 (2008) 1343-1356
14. Barter P.J., Caulfield M., Eriksson M., et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357 (2007) 2109-2122
15. Simon T., Boutouyrie P., Gompel A., et al., CASHMERE Investigators. Rationale, design and methods of the CASHMERE study. Fundam Clin Pharmacol 18 (2004) 131-138
16. Taylor A.J., Sullenberger L.E., Lee H.J., et al. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 110 (2004) 3512-3517
17. Blankenhorn D.H., Selzer R.H., Crawford D.W., et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation 88 (1993) 20-28